| A Study to Learn How Various Tablets of the Study Medicine Vepdegestrant Are Taken up Into the Blood of Healthy Adults (NCT06347861) | Pfizer | 2024-04-02 |
| Optimised CD33 (FL-33) CAR T Therapy for Refractory/Relapsed Acute Myeloid Leukaemia (NCT06326021) | Beijing GoBroad Hospital | 2024-04-02 |
| Safety and Preliminary Efficacy of Allogeneic Endothelial Progenitor Cells (EPCs) in Patients With Critical Limb Ischemia (NCT06359912) | Allife Medical Science and Technology Co., Ltd. | 2024-04-01 |
| Study to Evaluate the Drug-drug Interaction of JMKX001899 in Healthy Subjects (NCT06348290) | Jemincare | 2024-04-01 |
| A Study of GZR18 Tablet in Chinese Healthy Subjects (NCT06554054) | Gan and Lee Pharmaceuticals, USA | 2024-04-01 |
| Ketamine vs Ephedrine on Post Spinal Hypotension in Caesarean Delivery (NCT07034911) | Ain Shams University | 2024-04-01 |
| Administration of Venetoclax to Promote Apoptosis of HIV-infected Cells and Reduce the Size of the HIV Reservoir Among People Living With HIV on ART (NCT05668026) | University of Aarhus | 2024-04-01 |
| Intratumoral Injection of PV-001-DV Plus DC in Patients With Melanoma (NCT03990493) | PrimeVax Immuno-Oncology Inc. | 2024-04-01 |
| Result of tDCS in ASD Children With Comorbidities Like PANDAS, Rare Genetic Diseases or Autoimmune Disorders (NCT06368726) | Spanish Foundation for Neurometrics Development | 2024-04-01 |
| Intravenous Labetalol Versus Hydralazine in Preeclampsia (NCT06360601) | Tanta University | 2024-04-01 |
| Microelectrode Recordings From the Vagus Nerve in Awake Humans (NCT06016686) | University of Minnesota | 2024-04-01 |
| A Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma (NCT07075328) | Otsuka Medical Devices Co., Ltd. Japan | 2024-04-01 |
| Blinatumomab and Auto-HSCT Sandwich Strategy as Consolidation Therapy for B-ALL (NCT06507514) | The First Affiliated Hospital of Soochow University | 2024-04-01 |
| A Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics of SY-5007 in Healthy Subjects (NCT06332053) | Shouyao Holdings (Beijing) Co. LTD | 2024-04-01 |
| Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-treated With Immunotherapy (NCT06332950) | Baohui Han | 2024-04-01 |
| A Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of ConvitVax in Metastatic Breast Cancer (NCT06023277) | Jacinto Convit World Organization Inc. | 2024-04-01 |
| Abequolixron (RGX-104) and Durvalumab in Lung Cancer (NCT05911308) | UNC Lineberger Comprehensive Cancer Center | 2024-04-01 |
| Morphine, Midazolam and Dexmedetomidine in the Management of Acute Cardiogenic Pulmonary Edema, Safety and Efficacy (NCT06653244) | Menoufia University | 2024-04-01 |
| Application of 68Ga-NODAGA-SNA006 Positron Emission Tomography/Computed Tomography (PET/CT) in Tumors (NCT07059832) | First Hospital of China Medical University | 2024-04-01 |
| A Phase I Study of DDN-A-0101 in Healthy Volunteers and Elder People (NCT06367426) | Pharmacobio | 2024-04-01 |
| Efficacy of Hyaluronic Acid in Prevention of Acute Radiation Proctitis (NCT06469216) | Assiut University | 2024-04-01 |
| Gene Therapy for RPGR Gene Mutation-associated X-linked Retinitis Pigmentosa (NCT06492850) | Frontera Therapeutics | 2024-04-01 |
| FID-007 Followed by Standard of Care Surgery in Head and Neck Cancer (NCT06338657) | University of Southern California | 2024-04-01 |
| (TAA)-Specific Cytotoxic T-Lymphocytes to Pediatric Patients With Lymphomas (pediTACTAL). (NCT05134740) | Baylor College of Medicine | 2024-04-01 |
| Fecal Transplantation in Patients Colonic Diverticulitis (NCT06254625) | Odense University Hospital | 2024-04-01 |
| A Study to Investigate Safety, Tolerability, and Pharmacokinetics of Oral AZD0233 Compared With Placebo in Healthy Adult Participants. (NCT06381466) | AstraZeneca | 2024-04-01 |
| This Study Will Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of MET097 in Adult Participants With Overweight or Obesity (NCT06857617) | Metsera, a wholly owned subsidiary of Pfizer | 2024-04-01 |
| BGB-43395 Alone or as Part of Combination Therapies in Chinese Participants With HR+/HER2- Breast Cancer and Other Advanced Solid Tumors (NCT06253195) | BeOne Medicines | 2024-04-01 |
| A Randomized, Double-blind, Parallel-group, Two-arm, Multiple Dose, Multicenter, Bioequivalence Study With Clinical Endpoint in the Treatment of Subjects With Chronic Open-angle Glaucoma or Ocular Hypertension in Both Eyes (NCT06267274) | Amneal Pharmaceuticals, LLC | 2024-04-01 |
| A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion (NCT06158854) | AbbVie | 2024-04-01 |
| Remimazolam for Emergence Delirium Prevention in Children Undergoing Tonsillectomy (NCT07704437) | University Hospital of Split | 2024-04-01 |
| Evaluating PD-1/PD-L1 in Locally Advanced Rectal Cancer by Quantitative Fluorescence Molecular Endoscopy (NCT06304597) | University Medical Center Groningen | 2024-04-01 |
| Captopril Use on the Degree of Marrow Fibrosis in Bone Marrow Fibrosis/Myeloproliferative Neoplasms (NCT04629651) | Case Comprehensive Cancer Center | 2024-04-01 |
| A First-in-human Study of SCTB35 in Patients With Relapse/Refractory B-cell Non-Hodgkin Lymphoma (NCT06318884) | Sinocelltech Ltd. | 2024-04-01 |
| Nasal Inflammation Following Endotoxin Challenge in Patients With Asthma (NCT06270576) | National Jewish Health | 2024-04-01 |
| Molecularly Targeted Theranostic Approach for the Detection and Treatment of Metastatic Carcinomas (NCT06389123) | University of California, Davis | 2024-04-01 |
| A Study to Evaluate the Food Effects on Pharmacokinetics of SY-5007 Tablets in Healthy Subjects (NCT06325761) | Shouyao Holdings (Beijing) Co. LTD | 2024-04-01 |
| CLL-1 CAR-NK Cells for Relapsed/Refractory AML (NCT06307054) | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | 2024-04-01 |
| Stereotactic Body Radiation Therapy Followed by NALIRIFOX vs NALIRIFOX for Borderline Resectable Pancreatic Cancer (NCT06259058) | Tianjin Medical University Cancer Institute and Hospital | 2024-04-01 |
| F01 in the Treatment of Relapsed/Refractory Non-hodgkin's Lymphoma (NCT06206902) | Shanghai Simnova Biotechnology Co.,Ltd. | 2024-04-01 |
| The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies (NCT06552598) | Tongji Hospital | 2024-04-01 |
| Dexmedetomidine in Spinal Anesthesia Decreasing Post Spinal Shivering in Caesarean Section (NCT06318546) | Ain Shams University | 2024-04-01 |
| A Study of RC48-ADC Combined With Pyrotinib For Treatment of Local Advanced or Metastasis NSCLC With HER2 Mutation (NCT05745740) | RemeGen Co., Ltd. | 2024-04-01 |
| Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer (NCT06344156) | Sichuan University | 2024-04-01 |
| Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1 (NCT06071767) | National Institute of Allergy and Infectious Diseases (NIAID) | 2024-04-01 |
| A Study of Enlicitide Decanoate (MK-0616), Warfarin, and Lisinopril in Healthy Adult Participants (MK-0616-026) (NCT06772779) | Merck Sharp & Dohme LLC | 2024-04-01 |
| Unlocking New Avenues: Azithromycin Vs Erythromycin in Pre-term, Pre-mature Rupture of Membrane Management (NCT07394725) | District Headquarters Teaching Hospital Sahiwal | 2024-04-01 |
| BG1805 Injection in the Treatment of Relapsed or Refractory Acute Myeloid Leukemia in Children (NCT06347458) | Guangzhou Bio-gene Technology Co., Ltd | 2024-04-01 |
| Study of the Food Effects of Herombopag Olamine Tablets in Healthy Subjects. (NCT06346925) | Jiangsu HengRui Medicine Co., Ltd. | 2024-04-01 |
| Trifluridine/Tipiracil Combined With Cetuximab in the Treatment of Third-line and Above RAS/BRAF Wild-type mCRC (NCT06379399) | Wangxia LV | 2024-04-01 |
| Arm 1: Lysate Pulsed Dendritic Cells (PV-001-DC) in Patients With Melanoma (NCT03803397) | PrimeVax Immuno-Oncology Inc. | 2024-04-01 |
| Intratumoral Injection of Dengue Virus-1 #45AZ5 (PV-001-DV) in Patients With Melanoma (NCT03989895) | PrimeVax Immuno-Oncology Inc. | 2024-04-01 |
| A Double-Blind, Active-Controlled, Multiple-Ascending Dose Study of Aerosolized RSP-1502 in Subjects With CF and Chronic PA Lung Infection (NCT06016088) | Respirion Pharmaceuticals Pty Ltd | 2024-04-01 |
| A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors (NCT06265727) | Corbus Pharmaceuticals Inc. | 2024-04-01 |
| Drug-drug Interaction Study of HRS-1780 Tablets in Healthy Subjects (NCT06344936) | Shandong Suncadia Medicine Co., Ltd. | 2024-04-01 |
| Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer . (NCT05927857) | National Health Research Institutes, Taiwan | 2024-04-01 |
| Optimizing Reversal of HIV Latency With Combination Therapy (NCT06240520) | Erasmus Medical Center | 2024-04-01 |
| Concurrent vs. Sequential Cessation of Dual Cigarette and E-cigarette Use (NCT06027840) | Yale University | 2024-04-01 |
| Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer (NCT05833867) | Shilpa Gupta, MD | 2024-04-01 |
| A Bioequivalence Study of Sacubitril/Valsartan Film-coated Tablets Under Fasting Conditions (NCT06273254) | Viatris Inc. | 2024-04-01 |
| Single Ascending Dose, Multiple Ascending Dose, Food Effect Study (NCT06938204) | Innovo Therapeutics, Inc. | 2024-04-01 |
| A Study to Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and Above (NCT06361875) | Sanofi Pasteur, a Sanofi Company | 2024-04-01 |
| Bioequivalence Study of Generic Leflunomide 20 mg Film-coated Tablets and Reference Product Under Fasting Conditions (NCT06228443) | International Bio service | 2024-04-01 |
| Evaluation of [18F]AlF-NOTA-PCP2 PET/CT for PD-L1 Detection in Malignant Tumors (NCT06690216) | Man Hu | 2024-03-30 |
| Doxycycline in Type II Diabetes (NCT06329882) | Mostafa Bahaa | 2024-03-30 |
| Ethosomal Gel Bearing Losartan 5% for Keloid Treatment (NCT05893108) | Yuni Eka Anggraini | 2024-03-30 |
| A Clinical Trial of Quadrivalent Influenza Virus Split Vaccine (MDCK Cells) for Individuals Aged 6 Months and Above. (NCT06342349) | Shanghai Institute Of Biological Products | 2024-03-30 |
| A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SRSD107 in Healthy Chinese Subjects (NCT07655427) | Sirius Therapeutics Co., Ltd. | 2024-03-29 |
| NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial (NCT06066437) | M.D. Anderson Cancer Center | 2024-03-29 |
| A Study of the Interaction of Other Drugs With TAK-279 in Healthy Adults (NCT06290050) | Takeda | 2024-03-29 |
| A Dose-finding Study to Evaluate mRNA-3210 in Participants With Phenylketonuria (NCT06147856) | ModernaTX, Inc. | 2024-03-29 |
| Levothyroxine Supplementation for Heart Transplant Recipients (NCT06428097) | University of California, San Francisco | 2024-03-29 |
| IC14 (Atibuclimab) in Arrhythmogenic Cardiomyopathy (NCT06275893) | Implicit Bioscience | 2024-03-29 |
| AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas (NCT06340737) | Stanford University | 2024-03-29 |
| A Study to Learn About How Food and Esomeprazole Affect the Level of BAY2927088 in the Blood When Taken Together in Healthy Participants (NCT06378658) | Bayer | 2024-03-29 |
| Study to Evaluate the Pharmacokinetics and Safety of EXPAREL for Postoperative Analgesia in Subjects Undergoing Cardiac Surgery (NCT06271265) | Pacira Pharmaceuticals, Inc | 2024-03-29 |
| Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Ascending Doses BCD-261 in Healthy Subjects (NCT06715540) | Biocad | 2024-03-29 |
| A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of PC14586 in Healthy Participants (NCT06362642) | PMV Pharmaceuticals, Inc | 2024-03-28 |
| Compare the PK, Safety, and Immunogenicity of Process-Changed CMAB007 and Xolair in Healthy Adult Male Subjects (NCT07246252) | Taizhou Mabtech Pharmaceutical Co.,Ltd | 2024-03-28 |
| Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia Taking Stable Donepezil Treatment (MK-1167-007) (NCT06285240) | Merck Sharp & Dohme LLC | 2024-03-28 |
| CART-BCMA/CS1 in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT05950113) | Jonsson Comprehensive Cancer Center | 2024-03-28 |
| Safety, Tolerability, and Pharmacokinetic Study of TV-44749 in Chinese Patients With Schizophrenia (NCT06253546) | Teva Branded Pharmaceutical Products R&D LLC | 2024-03-28 |
| A Study to See How Safe a New Medicine (NNC6022-0001) is in Healthy People (NCT06336005) | Novo Nordisk A/S | 2024-03-28 |
| A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation and Strength of Suzetrigine (NCT06336096) | Vertex Pharmaceuticals Incorporated | 2024-03-28 |
| Open-label Trial Characterizing the PK of 3 SC Olanzapine Extended-release Formulations in Participants With Schizophrenia/Schizoaffective Disorder (NCT06319170) | Teva Branded Pharmaceutical Products R&D LLC | 2024-03-28 |
| A Phase 1 Study to Evaluate the Safety, Tolerability, Pharmacokinetic, Pharmacodynamic Profiles and Food Effect of CS32582 Capsules (NCT06224595) | Chipscreen Biosciences, Ltd. | 2024-03-28 |
| A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease (NCT06308978) | Fate Therapeutics | 2024-03-28 |
| Study of Autologous Tumor-Infiltrating Lymphocytes in Pediatric, Adolescent, and Young Adult Participants (NCT06566092) | Iovance Biotherapeutics, Inc. | 2024-03-28 |
| Spermatogonial Differentiation Via Testicular Organoid (NCT06841861) | CellARTs Inc. | 2024-03-28 |
| Safety and Efficacy of CD123-targeted CAR-NK for Relapsed/Refractory Acute Myeloid Leukemia or Blastic Plasmacytoid Dendritic Cell Neoplasm (NCT06006403) | Chongqing Precision Biotech Co., Ltd | 2024-03-28 |
| A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2) (NCT06220201) | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 2024-03-28 |
| A Clinical Study of Intismeran Autogene (V940) Treatment and Pembrolizumab in People With Bladder Cancer (V940-005/INTerpath-005) (NCT06305767) | Merck Sharp & Dohme LLC | 2024-03-28 |
| Effect of Erythromycin on the Absorption, Metabolism and Elimination of CHF6001 in Healthy Volunteers (NCT06395610) | Chiesi Farmaceutici S.p.A. | 2024-03-28 |
| A Study to Investigate the Safety and Pharmacokinetics of Lebrikizumab in Healthy Chinese Participants (NCT06243198) | Eli Lilly and Company | 2024-03-28 |
| Study of the RNR Inhibitor BBI-825 in Subjects With Tumors With Resistance Gene Amplifications (NCT06299761) | Boundless Bio, Inc. | 2024-03-28 |
| A Study of PEP07 (Checkpoint Kinase 1 Inhibitor) in Patients with Advanced or Metastatic Solid Tumors (NCT05983523) | PharmaEngine | 2024-03-27 |
| Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1 (NCT06083883) | M.D. Anderson Cancer Center | 2024-03-27 |
| Safety, Tolerability, and Efficacy of mFOLFIRINOX ± BNT321 as Adjuvant Therapy Following Curative Resection in Patients With Pancreatic Adenocarcinoma (NCT06069778) | BioNTech SE | 2024-03-27 |
| Phase I Study of sss40 Injection for Moderate-to-Severe Bone Metastatic Cancer Pain (NCT07008703) | Shenyang Sunshine Pharmaceutical Co., LTD. | 2024-03-27 |
| A Phase I Study to Evaluate the Safety, Pharmacokinetics and Antitumor Activity of HC010 in Patients With Advanced Solid Tumors (NCT06307925) | HC Biopharma Inc. | 2024-03-27 |